4//SEC Filing
PENWEST PHARMACEUTICALS CO 4
Accession 0000909012-08-000426
CIK 0001047188operating
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 2:23 PM ET
Size
13.1 KB
Accession
0000909012-08-000426
Insider Transaction Report
Form 4
PERCEPTIVE ADVISORS LLC
10% Owner
Transactions
- Purchase
Ordinary Shares
2008-03-04$5.00/sh+13,600$68,000→ 2,724,346 total(indirect: see footnote) - Purchase
Ordinary Shares
2008-03-05$5.00/sh+52,100$260,500→ 2,776,446 total(indirect: see footnote)
Bradley Scott
10% Owner
Transactions
- Purchase
Ordinary Shares
2008-03-05$5.00/sh+52,100$260,500→ 2,776,446 total(indirect: see footnote) - Purchase
Ordinary Shares
2008-03-04$5.00/sh+13,600$68,000→ 2,724,346 total(indirect: see footnote)
EDELMAN JOSEPH
10% Owner
Transactions
- Purchase
Ordinary Shares
2008-03-05$5.00/sh+52,100$260,500→ 2,776,446 total(indirect: see footnote) - Purchase
Ordinary Shares
2008-03-04$5.00/sh+13,600$68,000→ 2,724,346 total(indirect: see footnote)
Transactions
- Purchase
Ordinary Shares
2008-03-05$5.00/sh+52,100$260,500→ 2,776,446 total(indirect: see footnote) - Purchase
Ordinary Shares
2008-03-04$5.00/sh+13,600$68,000→ 2,724,346 total(indirect: see footnote)
Footnotes (2)
- [F1]This Form 4 is being filed by Joseph Edelman, Scott Bradley, Perceptive Life Science Master Fund Ltd. )"Master Fund") and Perceptive Advisors LLC ("Advisors").
- [F2]This amount reflects the amount of securities held by the Master Fund immediately following the transaction requiring the filing of this statement. Mr. Edelman is the managing member of Advisors, which in turn serves as the investment manager of Master Fund. Mr. Edelman and Mr. Bradley share dispositive power over 54,500 of such shares. Mr. Edelman has sole voting and dispositive power over the remainder of such shares. In accordance with Instruction 5(b)(iv) of Form 3, the entire amount of the Issuer's securities held by Master Fund is reported herein. Each of Mr. Edelman, Mr. Bradley and Advisors disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman, Mr. Bradley or Advisors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose
Documents
Issuer
PENWEST PHARMACEUTICALS CO
CIK 0001047188
Entity typeoperating
IncorporatedWA
Related Parties
1- filerCIK 0001047188
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 2:23 PM ET
- Size
- 13.1 KB